Review: UK medicines likely to be affected by the proposed European Medicines Agency's guidelines on phthalates.

Background: Phthalates are excipients in drug formulations. However, concerns have been raised about the effects of particular phthalates on reproduction and development. As a result the EMA has introduced guidelines for permitted daily exposure (PDE) limits for certain phthalates.